secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ardent Health, Inc. (ARDT)
CIK:        0001756655
Form:       8-K
Filed at:   2026-08-04T20:16:33+00:00
Accession:  0001628280-26-052598
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardent Health Q2 net income $17M ($0.12 EPS) vs $73M; Adjusted EBITDA $115M, down 32% YoY
--------------------------------------------------------------------------------

- Net income attributable to Ardent Health $17M ($0.12 diluted EPS) vs $73M ($0.52) in Q2 2025; revenue $1.62B, down 1.4% YoY.
- Adjusted EBITDA $115M, down 32.3% YoY; operating cash flow $197M, up 67% YoY.
- Reaffirmed FY2026 guidance: revenue $6.4B-$6.7B, Adjusted EBITDA $485M-$535M; lowered net income guidance to $110M-$163M.
- IMPACT program savings target raised to at least $70M in 2026 (from $55M); repurchased 1.4M shares for $13M in Q2.
- Admissions down 1.0%, surgeries down 2.9% YoY; adjusted admissions up 2.5%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756655/000162828026052598/0001628280-26-052598-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756655/000162828026052598/ardt-20260804.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-052598

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer